Papa Salif Sow MD, MS
He has focused his research on the development on diagnosis and treatment of opportunistic infections and on first line antiretroviral therapies and management strategies in resources limited countries. In 2002, Professor Sow was nominated Head of the Department of Infectious Diseases of the University of Dakar. Since 1998, he is the Clinical Coordinator of the Senegalese Initiative for Access to ARV and led a multidisciplinary team for scaling up this strategy in all the country. He has also undertaken several consultancies on HIV/AIDS care and treatment for UNAIDS and WHO Geneva.
He is a member of the WHO Writing Guidelines for Access to Care and Treatment in Resource Limited Settings, member of the STAC (Strategic Advisory Committee for HIV/AIDS) and he is also a member of the TRP (Technical Review Panel) of the GFATM during Round 4, 5, 6 and 7. He has many research collaboration mainly with the ANRS in France and the University of Washington Seattle (USA) focus on opportunistic infections and HIV therapies.
Dr Sow is a member of the WHO HIV/TB working group and he made a plenary communication on TB in people living with HIV during the International AIDS Conference organized by the IAS in 2004 in Bangkok. His current research interests include second line ARVtherapies in resources limited countries and HPV vaccine trial in young girls. Dr Sow is the President of the African Network for AIDS Physicians (ANEPA) and the Coordinator of the Regional Centre for Research and Training at Fann Hospital Dakar, Senegal.